FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/ALNY
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ALNY trades at $224.85, up 0.37% on the day, amid a bearish technical signal with the current price near the S1 support level of $224. The company demonstrates strong revenue growth, with 2025 revenue reaching $3.71 billion and net income turning positive at $313.75 million, marking a significant improvement from prior years of losses. Recent news includes a securities fraud investigation and continued momentum for its AMVUTTRA treatment.
The outlook is mixed; strong fundamentals and a bullish analyst consensus with a $347.23 price target suggest upside potential, but technical weakness, earnings misses, and legal risks present headwinds. Investment opportunity lies in the company's profitability turnaround and pipeline catalysts, though investors must weigh these against near-term volatility and competitive pressures.
Read full analysis

Key Stats

  • Market Cap
    $30.46B
  • Volume
    1,436,904
  • Sector
    Health
  • 52W High
    $481.59
  • 52W Low
    $205.48
  • Typical Hold Time
    41 Days
  • Enterprise Value
    $28.42B
  • Div Yield
    -
  • Trading Activity
    -
$225.29
52W Low: $205.48
30 Jul 2026
52W High: $481.59
29 Oct 2025

Track Alnylam Pharmaceuticals, Inc. (ALNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Alnylam Pharmaceuticals, Inc. has traded between a low of $205.48 and a high of $481.59, highlighting its annual price range. Buy and sell Alnylam Pharmaceuticals, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

Most Recent News

Content is generated by Aura AI

Bitget Wallet launches free USD and EUR virtual accounts for 100M users, enabling easy stablecoin access and cross-border payments.

Bitget Wallet introduced Virtual Account, allowing users to open free USD and EUR accounts within their self-custodial crypto wallet, powered by licensed partner Noah. Funds deposited convert automatically to stablecoins like USDT or USDC, usable for...

Market News
36 minutes ago
Na
Bullish
news icon
Bitget Wallet launches free USD and EUR virtual accounts for 100M users, enabling easy stablecoin access and cross-border payments.

KBC Group's capital remains well above ECB minimum requirements in 2026 SREP review.

The European Central Bank (ECB) has confirmed KBC Group's minimum capital requirements for 2026 following its Supervisory Review and Evaluation Process (SREP). KBC must maintain a fully loaded CET1 ratio of 10.94%, which includes various regulatory b...

Market News
36 minutes ago
Na
Bullish
news icon
KBC Group's capital remains well above ECB minimum requirements in 2026 SREP review.

KBC's capital remains well above ECB's minimum requirements for 2026 at 14.4% CET1 ratio.

The European Central Bank (ECB) has confirmed KBC Group's minimum capital requirements for 2026, maintaining the Pillar 2 Requirement at 1.95% and Pillar 2 Guidance at 1.00%. This results in an overall CET1 capital requirement of 10.94%. As of Q2 202...

Market News
36 minutes ago
Kbc Group
Bullish
news icon
KBC's capital remains well above ECB's minimum requirements for 2026 at 14.4% CET1 ratio.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $30.46B
  • Volume
    1,436,904
  • Sector
    Health
  • 52W High
    $481.59
  • 52W Low
    $205.48
  • Typical Hold Time
    41 Days
  • Enterprise Value
    $28.42B
  • Div Yield
    -
  • Trading Activity
    -
$225.29
52W Low: $205.48
30 Jul 2026
52W High: $481.59
29 Oct 2025

Track Alnylam Pharmaceuticals, Inc. (ALNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Alnylam Pharmaceuticals, Inc. has traded between a low of $205.48 and a high of $481.59, highlighting its annual price range. Buy and sell Alnylam Pharmaceuticals, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!